SBK-010

N/A

Report date: 2025/12/03 09:53:45

Base Information

Drug NameSBK-010
Drug Alias NameSBK010SBK-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTandem pore domain potassium channels inhibitorsPlatelet aggregation inhibitors
TargetsTandem pore domain potassium channels
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
Inactive CompaniesJinzhou Aohong Pharmaceutical Co Ltd
Active IndicationsIschemic Stroke
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A